dronabinol has been researched along with Memory Disorders in 55 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (3.64) | 18.7374 |
| 1990's | 3 (5.45) | 18.2507 |
| 2000's | 26 (47.27) | 29.6817 |
| 2010's | 20 (36.36) | 24.3611 |
| 2020's | 4 (7.27) | 2.80 |
| Authors | Studies |
|---|---|
| Choi, P; Ham, J; Kim, J; Kim, JC; Kim, T; Park, YT | 1 |
| Brown, SP; Hasegawa, Y; Jouroukhin, Y; Kamiya, A; Kim, J; Lutz, B; Madireddy, S; Miyahara, Y; Obayashi, M; Pletnikov, MV; Sawa, A; Ursini, G; Xiong, F; Zhu, X | 1 |
| Gu, H; Lewis, DA; Mathai, DS; Sampson, AR; Verrico, CD | 1 |
| Gabaglio, M; Manenti, C; Parolaro, D; Prini, P; Rubino, T; Zamberletti, E | 1 |
| Haile, CN; Holst, M; Hussain, MZ; Keller, J; Kosten, TR; Mathai, DS; Newton, TF; Rodgman, C; Verrico, CD | 1 |
| Calabrese, EJ; Rubio-Casillas, A | 1 |
| Taffe, MA; Vandewater, SA; Wright, MJ | 1 |
| Mechoulam, R; Parker, L | 1 |
| Carbuto, M; D'Souza, DC; Elander, J; Pittman, B; Radhakrishnan, R; Ranganathan, M; Schnakenberg, A; Sewell, RA | 1 |
| Cousijn, J; de Haan, L; Goudriaan, AE; Koenders, L; van den Brink, W; Vingerhoets, WA; Wiers, RW | 1 |
| Bertoglio, LJ; Galve-Roperh, I; Gazarini, L; Guimaraes, FS; Stern, CA; Takahashi, RN; Vanvossen, AC; Zuardi, AW | 1 |
| Behlke, I; Bhattacharyya, S; Kambeitz, J; Murray, R; Schoeler, T | 1 |
| Ciccone, CD | 1 |
| Banister, SD; Kassiou, M; Kevin, RC; McGregor, IS; Mitchell, AJ; Moir, M; Stuart, J; Wood, KE | 1 |
| D'Souza, DC; Perry, E; Pittman, B; Simen, A | 1 |
| Chocyk, A; Dudys, D; Maćkowiak, M; Wedzony, K | 1 |
| Arnold, JC; Boucher, AA; Brayda-Bruno, L; Metna-Laurent, M; Micheau, J; Mons, N; Vivier, L | 1 |
| Lichtman, AH; Thorpe, AJ; Wise, LE | 1 |
| Busquets-Garcia, A; Lutz, B; Maldonado, R; Marsicano, G; Ozaita, A; Puighermanal, E | 1 |
| Katona, I; Mackie, K | 1 |
| Bromley-Brits, K; Cai, F; Chen, B; He, G; Song, W; Zhang, X | 1 |
| Brüne, M; Della, B; Juckel, G; Norra, C; Roser, P; Uhl, I | 1 |
| Curran, HV; Freeman, TP; Morgan, CJ; Schafer, G | 1 |
| Assaife-Lopes, N; Brett, RR; Pratt, JA; Ribeiro, JA; Sebastião, AM; Sousa, VC | 1 |
| Conti, CL; Nakamura-Palacios, EM; Rodrigues, LC | 1 |
| Lichtman, AH; Long, KA; Middleton, LS; Selley, DE; Sim-Selley, LJ; Varvel, SA; Wiebelhaus, JM; Wise, LE | 1 |
| Egashira, N; Fujiwara, M; Iwasaki, K; Manome, N; Mishima, K; Oishi, R | 1 |
| Taffe, MA | 1 |
| Abdullah, RA; Cravatt, BF; Lichtman, AH; Long, JZ; Long, KA; Wise, LE | 1 |
| Bonaccorso, S; Brenneisen, R; Englund, A; Feilding, A; Hague, D; Holt, D; Kane, F; Kapur, S; Morrison, PD; Murray, RM; Nottage, J; Reichenberg, A; Stone, JM; Walker, L | 1 |
| Antonelli, L; Biondini, M; Ciccocioppo, R; Massi, M; Perfumi, M; Pompei, P | 1 |
| Egashira, N; Fujiwara, M; Iwasaki, K; Matsumoto, Y; Mishima, K | 1 |
| Christie, BR; Fox, CJ; Froc, DJ; Gorzalka, BB; Hill, MN | 1 |
| Mallet, PE; McGregor, IS; O'Shea, M; Singh, ME | 1 |
| Egashira, N; Fujiwara, M | 1 |
| Mallet, PE; McGregor, IS; Young, JM | 1 |
| Friede, T; Nurmikko, TJ; Rog, DJ; Young, CA | 1 |
| Egashira, N; Fujioka, M; Fujiwara, M; Iwasaki, K; Matsumoto, Y; Matsushita, M; Mishima, K; Nishimura, R; Shoyama, Y | 1 |
| Bechara, A; Lamers, CT; Ramaekers, JG; Rizzo, M | 1 |
| Egashira, N; Fujiwara, M; Iwasaki, K; Kurauchi, K; Manome, N; Matsumoto, Y; Mishima, K; Shoyama, Y | 1 |
| Linszen, D; van Amelsvoort, T | 1 |
| Chocyk, A; Maćkowiak, M; Markowicz-Kula, K; Wedzony, K | 1 |
| Goonawardena, AV; Hampson, RE; Pertwee, RG; Riedel, G; Robinson, L | 1 |
| Egashira, N; Egawa, T; Fujiwara, M; Hayakawa, K; Hazekawa, M; Irie, K; Iwasaki, K; Kitamura, Y; Mishima, K; Nishimura, R; Orito, K; Sano, K; Uchida, N | 1 |
| Egashira, N; Fujiwara, M; Ishigami, N; Iwasaki, K; Mishima, K; Oishi, R | 1 |
| Garavan, H; Hester, R; Nestor, L; Roberts, G | 1 |
| Batt, JR; De Rossett, SE; Drew, WG; Weet, CR | 1 |
| Ellinwood, EH; Johnson, K; Mathew, RJ; Wilson, WH | 1 |
| Copeland, K; Davis, CM; Fletcher, JM; Francis, DJ; Krauskopf, D; Morris, R; Naus, MJ; Page, JB; Satz, P | 1 |
| Beninger, RJ; Mallet, PE | 1 |
| Gruber, AJ; Hudson, JI; Huestis, MA; Pope, HG; Yurgelun-Todd, D | 1 |
| Da, S; Takahashi, RN | 1 |
| Schwartz, RH | 1 |
| Egashira, N; Fujii, M; Fujiwara, M; Hirosawa, N; Iwasaki, K; Matsumoto, Y; Mishima, K | 1 |
| Hooker, WD; Jones, RT | 1 |
7 review(s) available for dronabinol and Memory Disorders
| Article | Year |
|---|---|
Neurobiological mechanisms underlying cannabis-induced memory impairment.
Topics: Animals; Brain; Dronabinol; Hallucinogens; Humans; Marijuana Use; Memory Disorders; Receptor, Cannabinoid, CB1 | 2020 |
Biphasic effects of THC in memory and cognition.
Topics: Age Factors; Alzheimer Disease; Animals; Cognition; Cognition Disorders; Disease Models, Animal; Dose-Response Relationship, Drug; Dronabinol; Hippocampus; Humans; Marijuana Smoking; Memory Disorders; Memory, Short-Term; Neurogenesis; Nootropic Agents; Receptor, Cannabinoid, CB1 | 2018 |
The effects of cannabis on memory function in users with and without a psychotic disorder: findings from a combined meta-analysis.
Topics: Adult; Cannabinoid Receptor Agonists; Dronabinol; Humans; Memory; Memory Disorders; Psychotic Disorders | 2016 |
Medical Marijuana: Just the Beginning of a Long, Strange Trip?
Topics: Cannabidiol; Cognition Disorders; Confusion; Controlled Substances; Depression; Dronabinol; Drug Administration Routes; Hallucinations; Heart; Humans; Lung; Marijuana Abuse; Medical Marijuana; Memory Disorders; Muscle Spasticity; Nausea; Pain; Physical Therapists; Postural Balance; Professional Role; Vomiting | 2017 |
New perspectives in the studies on endocannabinoid and cannabis: abnormal behaviors associate with CB1 cannabinoid receptor and development of therapeutic application.
Topics: Animals; Behavior, Animal; Dronabinol; Encephalomyelitis, Autoimmune, Experimental; Glutamic Acid; Humans; Memory Disorders; Receptor, Cannabinoid, CB1 | 2004 |
Cannabis and psychosis: an update on course and biological plausible mechanisms.
Topics: Brain; Causality; Cerebrovascular Circulation; Cognition Disorders; Comorbidity; Dopamine; Dronabinol; Humans; Marijuana Abuse; Memory Disorders; Neuropsychological Tests; Positron-Emission Tomography; Psychoses, Substance-Induced; Risk Factors; Tomography, Emission-Computed, Single-Photon | 2007 |
Marijuana: a decade and a half later, still a crude drug with underappreciated toxicity.
Topics: Adolescent; Adult; Cannabis; Dronabinol; Drug and Narcotic Control; Humans; Internet; Male; Marijuana Abuse; Memory Disorders; Memory, Short-Term; Phytotherapy; United States | 2002 |
7 trial(s) available for dronabinol and Memory Disorders
| Article | Year |
|---|---|
Guanfacine Attenuates Adverse Effects of Dronabinol (THC) on Working Memory in Adolescent-Onset Heavy Cannabis Users: A Pilot Study.
Topics: Adolescent; Adrenergic alpha-2 Receptor Agonists; Adult; Analysis of Variance; Blood Pressure; Cannabinoid Receptor Agonists; Cross-Over Studies; Double-Blind Method; Dronabinol; Female; Guanfacine; Heart Rate; Humans; Male; Marijuana Smoking; Memory Disorders; Memory, Short-Term; Middle Aged; Neuropsychological Tests; Pilot Projects; Young Adult | 2018 |
Preliminary evidence of cannabinoid effects on brain-derived neurotrophic factor (BDNF) levels in humans.
Topics: Adolescent; Adult; Behavior; Brain-Derived Neurotrophic Factor; Cognition; Double-Blind Method; Dronabinol; Enzyme-Linked Immunosorbent Assay; Female; Hallucinogens; Humans; Injections, Intravenous; Male; Marijuana Smoking; Memory Disorders; Middle Aged; Perception; Young Adult | 2009 |
Cannabidiol inhibits THC-elicited paranoid symptoms and hippocampal-dependent memory impairment.
Topics: Adult; Cannabidiol; Cannabis; Cognitive Dysfunction; Double-Blind Method; Dronabinol; Drug Interactions; Female; Hippocampus; Humans; Learning; Male; Memory Disorders; Paranoid Disorders | 2013 |
Randomized, controlled trial of cannabis-based medicine in central pain in multiple sclerosis.
Topics: Administration, Oral; Adult; Aged; Analgesics; Cannabinoids; Central Nervous System; Disorders of Excessive Somnolence; Dizziness; Dose-Response Relationship, Drug; Double-Blind Method; Dronabinol; Female; Humans; Male; Memory Disorders; Middle Aged; Multiple Sclerosis; Pain Measurement; Pain Threshold; Pain, Intractable; Phytotherapy; Placebos; Plant Preparations; Sleep Wake Disorders; Treatment Outcome | 2005 |
Cognitive function and mood in MDMA/THC users, THC users and non-drug using controls.
Topics: Adult; Amphetamine-Related Disorders; Anxiety; Cognition Disorders; Decision Making; Depression; Discrimination Learning; Dronabinol; Drug Synergism; Female; Hallucinogens; Humans; Male; Marijuana Abuse; Memory Disorders; N-Methyl-3,4-methylenedioxyamphetamine; Neuropsychological Tests; Problem Solving; Reaction Time; Serotonin Agents; Set, Psychology | 2006 |
Effects of marijuana on performance of a computerized cognitive-neuromotor test battery.
Topics: Adult; Blood Pressure; Cannabis; Cognition Disorders; Diagnosis, Computer-Assisted; Double-Blind Method; Dronabinol; Heart Rate; Humans; Male; Memory Disorders; Motor Skills; Reaction Time; Self-Assessment; Substance-Related Disorders; Task Performance and Analysis | 1994 |
Increased susceptibility to memory intrusions and the Stroop interference effect during acute marijuana intoxication.
Topics: Adult; Arousal; Association; Attention; Cognition Disorders; Color Perception; Double-Blind Method; Dronabinol; Humans; Male; Memory Disorders; Reading; Verbal Behavior | 1987 |
41 other study(ies) available for dronabinol and Memory Disorders
| Article | Year |
|---|---|
The Cannabinoids, CBDA and THCA, Rescue Memory Deficits and Reduce Amyloid-Beta and Tau Pathology in an Alzheimer's Disease-like Mouse Model.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Cannabidiol; Cannabinoids; Cannabis; Dronabinol; Memory Disorders; Mice; Neuroprotective Agents | 2023 |
Microglial cannabinoid receptor type 1 mediates social memory deficits in mice produced by adolescent THC exposure and 16p11.2 duplication.
Topics: Animals; Cannabinoid Receptor Agonists; DNA Copy Number Variations; Dronabinol; Memory Disorders; Mice; Microglia; Receptors, Cannabinoid | 2023 |
Recovery from impaired working memory performance during chronic Δ-9-tetrahydrocannabinol administration to adolescent rhesus monkeys.
Topics: Administration, Intravenous; Age Factors; Animals; Dronabinol; Male; Memory Disorders; Memory, Short-Term; Recovery of Function; Time Factors | 2020 |
Cannabidiol attenuates deficits of visuospatial associative memory induced by Δ(9) tetrahydrocannabinol.
Topics: Animals; Behavior, Animal; Cannabidiol; Cognition; Dronabinol; Functional Laterality; Macaca mulatta; Male; Memory; Memory Disorders; Models, Animal; Molecular Sequence Data; Motivation; Motor Activity; Time Factors | 2013 |
Towards a better cannabis drug.
Topics: Animals; Behavior, Animal; Cannabidiol; Cognition; Dronabinol; Male; Memory; Memory Disorders | 2013 |
Effects of Δ9-tetrahydrocannabinol in individuals with a familial vulnerability to alcoholism.
Topics: Affect; Alcoholism; Attention; Dose-Response Relationship, Drug; Double-Blind Method; Dronabinol; Executive Function; Family; Female; Genetic Predisposition to Disease; Humans; Male; Memory Disorders; Perception; Psychotropic Drugs; Reward; Spatial Memory; Young Adult | 2014 |
Relationship between working-memory network function and substance use: a 3-year longitudinal fMRI study in heavy cannabis users and controls.
Topics: Adolescent; Adult; Age of Onset; Analysis of Variance; Behavior, Addictive; Brain; Brain Mapping; Case-Control Studies; Disease Progression; Dronabinol; Female; Humans; Image Interpretation, Computer-Assisted; Linear Models; Longitudinal Studies; Magnetic Resonance Imaging; Male; Marijuana Abuse; Memory Disorders; Memory, Short-Term; Nerve Net; Neuropsychological Tests; Psychotropic Drugs; Risk Factors; Severity of Illness Index; Substance-Related Disorders; Young Adult | 2014 |
Δ9-Tetrahydrocannabinol alone and combined with cannabidiol mitigate fear memory through reconsolidation disruption.
Topics: Analysis of Variance; Animals; Cannabidiol; Disease Models, Animal; Dose-Response Relationship, Drug; Dronabinol; Drug Combinations; Fear; Male; Maze Learning; Memory; Memory Disorders; Rats; Rats, Wistar; Time Factors | 2015 |
Acute and residual effects in adolescent rats resulting from exposure to the novel synthetic cannabinoids AB-PINACA and AB-FUBINACA.
Topics: Animals; Cannabinoid Receptor Agonists; Cannabinoids; Dronabinol; Endocannabinoids; Illicit Drugs; Indazoles; Locomotion; Male; Memory Disorders; Rats; Rats, Wistar; Receptor, Cannabinoid, CB1; Valine | 2017 |
Activation of CB1 cannabinoid receptors impairs memory consolidation and hippocampal polysialylated neural cell adhesion molecule expression in contextual fear conditioning.
Topics: Animals; Conditioning, Psychological; Dentate Gyrus; Doublecortin Domain Proteins; Doublecortin Protein; Dronabinol; Fear; Freezing Reaction, Cataleptic; Gene Expression; Ki-67 Antigen; Male; Memory Disorders; Microtubule-Associated Proteins; Neural Cell Adhesion Molecule L1; Neuropeptides; Piperidines; Pyrazoles; Rats; Rats, Wistar; Receptor, Cannabinoid, CB1; Sialic Acids | 2009 |
Chronic treatment with Delta(9)-tetrahydrocannabinol impairs spatial memory and reduces zif268 expression in the mouse forebrain.
Topics: Animals; Dose-Response Relationship, Drug; Dronabinol; Drug Tolerance; Early Growth Response Protein 1; Hippocampus; Male; Maze Learning; Memory; Memory Disorders; Mice; Mice, Inbred C57BL; Motor Activity; Prefrontal Cortex; Reversal Learning; Spatial Behavior | 2009 |
Hippocampal CB(1) receptors mediate the memory impairing effects of Delta(9)-tetrahydrocannabinol.
Topics: Analysis of Variance; Animals; Catheterization; Central Nervous System Agents; Cyclohexanols; Dronabinol; Hippocampus; Male; Maze Learning; Memory Disorders; Memory, Short-Term; Microinjections; Piperidines; Psychotropic Drugs; Pyrazoles; Random Allocation; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Rimonabant | 2009 |
Cannabinoid modulation of hippocampal long-term memory is mediated by mTOR signaling.
Topics: Animals; Anisomycin; Central Nervous System Agents; Cognition; Dronabinol; gamma-Aminobutyric Acid; Glutamic Acid; Hippocampus; Male; Memory; Memory Disorders; Mice; Mice, Knockout; Neurons; Protein Kinases; Protein Synthesis Inhibitors; Receptor, Cannabinoid, CB1; Receptors, N-Methyl-D-Aspartate; Ribosomal Protein S6 Kinases, 70-kDa; Signal Transduction; Sirolimus; TOR Serine-Threonine Kinases | 2009 |
Get stoned in GABAergic synapses.
Topics: Animals; Axons; Carrier Proteins; Dronabinol; gamma-Aminobutyric Acid; Glutamic Acid; Hippocampus; Interneurons; Long-Term Potentiation; Memory; Memory Disorders; Mice; Phosphotransferases (Alcohol Group Acceptor); Presynaptic Terminals; Pyramidal Cells; Receptor, Cannabinoid, CB1; Receptors, Cholecystokinin; Ribosomal Protein S6 Kinases, 70-kDa; Signal Transduction; Synapses; TOR Serine-Threonine Kinases | 2009 |
Effect of synthetic cannabinoid HU210 on memory deficits and neuropathology in Alzheimer's disease mouse model.
Topics: Alzheimer Disease; Amyloid beta-Protein Precursor; Animals; Brain; Cannabinoid Receptor Modulators; Cognition Disorders; Conditioning, Psychological; Disease Models, Animal; Dronabinol; Female; Humans; Male; Maze Learning; Memory; Memory Disorders; Mice; Mice, Transgenic; Neuroprotective Agents; Plaque, Amyloid; Treatment Failure | 2010 |
Auditory mismatch negativity deficits in long-term heavy cannabis users.
Topics: Acoustic Stimulation; Adult; Auditory Cortex; Auditory Perception; Cognition Disorders; Contingent Negative Variation; Dronabinol; Electroencephalography; Evoked Potentials, Auditory; Female; Hallucinogens; Humans; Male; Marijuana Abuse; Memory Disorders; Receptors, Cannabinoid; Time | 2010 |
Impact of cannabidiol on the acute memory and psychotomimetic effects of smoked cannabis: naturalistic study: naturalistic study [corrected].
Topics: Adolescent; Alcohol Drinking; Analysis of Variance; Cannabidiol; Cannabinoids; Dronabinol; Female; Humans; Male; Marijuana Smoking; Memory; Memory Disorders; Mental Recall; Psychiatric Status Rating Scales; Receptor, Cannabinoid, CB1; Saliva; United Kingdom; Verbal Learning; Young Adult | 2010 |
Regulation of hippocampal cannabinoid CB1 receptor actions by adenosine A1 receptors and chronic caffeine administration: implications for the effects of Δ9-tetrahydrocannabinol on spatial memory.
Topics: Adenosine A1 Receptor Antagonists; Animals; Caffeine; Chronic Disease; Dronabinol; Hippocampus; Male; Memory; Memory Disorders; Mice; Mice, Inbred C57BL; Psychotropic Drugs; Rats; Rats, Wistar; Receptor, Adenosine A1; Receptor, Cannabinoid, CB1 | 2011 |
Clozapine and SCH 23390 prevent the spatial working memory disruption induced by Δ9-THC administration into the medial prefrontal cortex.
Topics: Animals; Benzazepines; Clozapine; Disease Models, Animal; Dopamine Antagonists; Dronabinol; Male; Maze Learning; Memory Disorders; Prefrontal Cortex; Psychotropic Drugs; Rats; Rats, Wistar | 2011 |
delta(9)-Tetrahydrocannabinol-dependent mice undergoing withdrawal display impaired spatial memory.
Topics: Animals; Dose-Response Relationship, Drug; Dronabinol; Male; Marijuana Abuse; Maze Learning; Memory Disorders; Memory, Short-Term; Mice; Mice, Inbred C57BL; Piperidines; Pyrazoles; Rimonabant; Spatial Behavior; Substance Withdrawal Syndrome | 2011 |
Involvement of opioid system in cognitive deficits induced by ∆⁹-tetrahydrocannabinol in rats.
Topics: Animals; Behavior, Animal; Cognition Disorders; Dronabinol; Male; Maze Learning; Memory Disorders; Narcotic Antagonists; Rats; Rats, Wistar; Receptors, Opioid; Receptors, Opioid, kappa; Receptors, Opioid, mu | 2012 |
Δ⁹Tetrahydrocannabinol impairs visuo-spatial associative learning and spatial working memory in rhesus macaques.
Topics: Animals; Association Learning; Behavior, Animal; Cannabinoid Receptor Agonists; Cognition; Cognition Disorders; Dronabinol; Macaca mulatta; Male; Memory Disorders; Memory, Short-Term; Motor Skills; Motor Skills Disorders; Neurotoxicity Syndromes; Pattern Recognition, Visual; Psychotropic Drugs; Random Allocation; Receptor, Cannabinoid, CB1; Spatial Behavior; Visual Perception | 2012 |
Dual fatty acid amide hydrolase and monoacylglycerol lipase blockade produces THC-like Morris water maze deficits in mice.
Topics: Amidohydrolases; Animals; Dronabinol; Maze Learning; Memory Disorders; Mice; Mice, Inbred C57BL; Mice, Knockout; Monoacylglycerol Lipases | 2012 |
Memory impairment following combined exposure to delta(9)-tetrahydrocannabinol and ethanol in rats.
Topics: Alcohol Drinking; Animals; Central Nervous System Depressants; Discrimination, Psychological; Dronabinol; Drug Interactions; Ethanol; Form Perception; Hallucinogens; Male; Memory Disorders; Motor Activity; Rats | 2002 |
Involvement of reduced acetylcholine release in Delta9-tetrahydrocannabinol-induced impairment of spatial memory in the 8-arm radial maze.
Topics: Acetylcholine; Animals; Cerebral Cortex; Cholinesterase Inhibitors; Cognition Disorders; Dronabinol; Hallucinogens; Hippocampus; Male; Maze Learning; Memory; Memory Disorders; Microdialysis; Physostigmine; Rats; Rats, Wistar; Space Perception; Tacrine | 2002 |
Prolonged cannabinoid treatment results in spatial working memory deficits and impaired long-term potentiation in the CA1 region of the hippocampus in vivo.
Topics: Animals; Behavior, Animal; Cannabinoids; Dronabinol; Electrophysiology; Hippocampus; Long-Term Potentiation; Male; Maze Learning; Memory Disorders; Memory, Short-Term; Rats; Rats, Long-Evans; Reaction Time; Time; Time Factors | 2004 |
Chronic cannabinoid exposure produces lasting memory impairment and increased anxiety in adolescent but not adult rats.
Topics: Aging; Animals; Anxiety; Behavior, Animal; Cannabinoids; Cognition; Conditioning, Operant; Cyclohexanols; Dronabinol; Exploratory Behavior; Female; Hallucinogens; Interpersonal Relations; Learning; Memory Disorders; Memory, Short-Term; Motor Activity; Psychomotor Performance; Rats; Rats, Wistar | 2004 |
Co-administration of THC and MDMA ('ecstasy') synergistically disrupts memory in rats.
Topics: Analysis of Variance; Animals; Behavior, Animal; Discrimination, Psychological; Dronabinol; Drug Combinations; Drug Synergism; Hallucinogens; Male; Maze Learning; Memory; Memory Disorders; N-Methyl-3,4-methylenedioxyamphetamine; Rats; Rats, Wistar; Spatial Behavior | 2005 |
Low dose citalopram reverses memory impairment and electroconvulsive shock-induced immobilization.
Topics: Animals; Brain Chemistry; Citalopram; Dronabinol; Electroshock; Hallucinogens; Male; Memory Disorders; Microdialysis; Muscarinic Agonists; Oxotremorine; Parasympathetic Nervous System; Rats; Rats, Wistar; Scopolamine; Selective Serotonin Reuptake Inhibitors; Tremor | 2006 |
Kamikihi-to, a Kampo medicine, ameliorates impairment of spatial memory in rats.
Topics: Animals; Dronabinol; Drugs, Chinese Herbal; Male; Maze Learning; Medicine, Kampo; Memory; Memory Disorders; Mice; Mice, Inbred Strains; Oxotremorine; Rats; Rats, Wistar; Scopolamine; Tremor | 2007 |
Acute activation of CB1 cannabinoid receptors transiently decreases PSA-NCAM expression in the dentate gyrus of the rat hippocampus.
Topics: Animals; Cannabinoids; Cell Count; Cell Differentiation; Cell Proliferation; Dentate Gyrus; Dose-Response Relationship, Drug; Doublecortin Domain Proteins; Doublecortin Protein; Down-Regulation; Dronabinol; Excitatory Amino Acid Antagonists; Immunohistochemistry; Ki-67 Antigen; Male; Memory Disorders; Microtubule-Associated Proteins; Neural Cell Adhesion Molecule L1; Neuronal Plasticity; Neurons; Neuropeptides; Piperidines; Pyrazoles; Rats; Rats, Wistar; Receptor, Cannabinoid, CB1; Sialic Acids; Stem Cells; Time Factors | 2007 |
The synthetic cannabinoid HU210 induces spatial memory deficits and suppresses hippocampal firing rate in rats.
Topics: Animals; Behavior, Animal; Cannabinoids; Dronabinol; Electrophysiology; Hippocampus; Male; Maze Learning; Memory; Memory Disorders; Morpholines; Motor Activity; Neurons; Piperidines; Pyrazoles; Rats; Receptor, Cannabinoid, CB1; Rimonabant; Space Perception | 2007 |
Cannabidiol potentiates pharmacological effects of Delta(9)-tetrahydrocannabinol via CB(1) receptor-dependent mechanism.
Topics: Animals; Body Temperature; Brain; Cannabidiol; Catalepsy; Dose-Response Relationship, Drug; Dronabinol; Drug Synergism; Hypothermia; Male; Maze Learning; Memory Disorders; Mice; Motor Activity; Psychotropic Drugs; Receptor, Cannabinoid, CB1 | 2008 |
Delta9-Tetrahydrocannabinol-induced cognitive deficits are reversed by olanzapine but not haloperidol in rats.
Topics: Acetylcholine; Animals; Antipsychotic Agents; Behavior, Animal; Benzodiazepines; Cognition Disorders; Dronabinol; Extracellular Space; Hallucinogens; Haloperidol; Hippocampus; Humans; Male; Marijuana Abuse; Maze Learning; Memory Disorders; Microdialysis; Olanzapine; Rats; Rats, Wistar | 2008 |
Deficits in learning and memory: parahippocampal hyperactivity and frontocortical hypoactivity in cannabis users.
Topics: Adult; Data Interpretation, Statistical; Dronabinol; Face; Female; Hallucinogens; Humans; Image Processing, Computer-Assisted; Learning Disabilities; Magnetic Resonance Imaging; Male; Marijuana Abuse; Memory; Memory Disorders; Oxygen; Parahippocampal Gyrus; Prefrontal Cortex; Psychomotor Performance; Substance Withdrawal Syndrome; Surveys and Questionnaires | 2008 |
Effects of hippocampal brain damage on auditory and visual recent memory: comparison with marijuana-intoxicated subjects.
Topics: Acute Disease; Adolescent; Adult; Aged; Auditory Perception; Dronabinol; Female; Hippocampus; Humans; Male; Marijuana Abuse; Memory Disorders; Middle Aged; Paired-Associate Learning; Psychological Tests; Retention, Psychology; Visual Perception | 1980 |
Cognitive correlates of long-term cannabis use in Costa Rican men.
Topics: Adult; Age Factors; Attention; Cognition Disorders; Cohort Studies; Costa Rica; Dronabinol; Female; Follow-Up Studies; Humans; Male; Marijuana Abuse; Memory Disorders; Memory, Short-Term; Middle Aged; Motor Skills; Pregnancy; Psychomotor Performance | 1996 |
The cannabinoid CB1 receptor antagonist SR141716A attenuates the memory impairment produced by delta9-tetrahydrocannabinol or anandamide.
Topics: Animals; Arachidonic Acids; Discrimination Learning; Dronabinol; Endocannabinoids; Male; Memory Disorders; Piperidines; Polyunsaturated Alkamides; Pyrazoles; Rats; Rats, Wistar; Receptors, Cannabinoid; Receptors, Drug; Rimonabant | 1998 |
Neuropsychological performance in long-term cannabis users.
Topics: Adolescent; Adult; Cognition Disorders; Comorbidity; Dronabinol; Female; Humans; Male; Marijuana Abuse; Memory Disorders; Middle Aged; Neuropsychological Tests; Regression Analysis; Research Design; Severity of Illness Index; Substance Abuse Detection; Time Factors; Verbal Learning | 2001 |
SR 141716A prevents delta 9-tetrahydrocannabinol-induced spatial learning deficit in a Morris-type water maze in mice.
Topics: Animals; Dose-Response Relationship, Drug; Dronabinol; Male; Maze Learning; Memory Disorders; Mice; Piperidines; Psychotropic Drugs; Pyrazoles; Reaction Time; Receptors, Cannabinoid; Receptors, Drug; Rimonabant; Spatial Behavior | 2002 |
Characteristics of learning and memory impairment induced by delta9-tetrahydrocannabinol in rats.
Topics: Animals; Avoidance Learning; Discrimination Learning; Dronabinol; Hallucinogens; Injections, Intraventricular; Learning Disabilities; Maze Learning; Memory Disorders; Memory, Short-Term; Muscarinic Agonists; Muscarinic Antagonists; Pilocarpine; Piperidines; Pyrazoles; Rats; Rimonabant; Scopolamine | 2001 |